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Abstract 
Background:  Nausea and vomiting of pregnancy (NVP) are common symptoms experienced during pregnancy. Both 
mild and severe symptoms can have significant morbidities and socioeconomic impact. Despite its frequency and 
associated distress, its exact cause is unknown. No study was done addressing this particular important issue in our 
country and this study will serve as a bench mark for future work on the topic in the Ethiopian context.  
Objective: To assess nausea and vomiting of pregnancy on ANC (antenatal care) clients of three hospitals of Addis 
Ababa. 
Methods: A descriptive facility based cross-sectional study, done in three teaching hospitals of Addis Ababa, the 
capital city of Ethiopia. Semi-structured questionnaires were administered to random sample of 384 pregnant women. 
Descriptive statistic was used to summarize data. P-value and χ² test were used to measure associations.  
Results: The prevalence of nausea and vomiting of pregnancy was 74.5%, with 4.4% being admitted for severe 
symptoms. It was found out that 91% had symptoms in the 1st trimester, 2.1% after mid pregnancy, and 85% were 
triggered by smell and taste. Primigravidity, nulliparity, excessive salivation and food aversion were significantly 
associated with nausea and vomiting connected with pregnancy. Significant associations were also observed between 
admission for severity and being unmarried, loss to work, affected relationship, more frequent vomiting, and early 
onset of symptoms. Severe frequency of vomiting was a major factor associated with admission for severity and loss to 
work. 
Conclusion and recommendation:  Nausea and vomiting of pregnancy found in this study were similar to other 
studies. Sensory stimuli were major trigger of symptoms and more frequent vomiting was linked with more admission. 
Importance of supportive measures, rest, counseling and advice on diet and life style modification needs to be 
underscored and early treatment of vomiting need to be considered.  [Ethiop. J. Health Dev. 2013;27(3):200-207] 
 
Introduction 
Gastrointestinal and food-related disorders of pregnancy 
such as excessive salivation, food aversions, pica, nausea 
and vomiting in mild and extreme forms (emesis and 
hyperemesis gravidarum) are all principally symptoms of 
first and early second trimester pregnancy that can 
occasionally persist until term and delivery. Hyperemesis 
gravidarum is the most severe form of nausea and 
vomiting in pregnancy and is characterized by intractable 
nausea and vomiting that leads to dehydration, electrolyte 
and metabolic disturbances, and nutritional deficiencies 
that may require hospitalization. They are generally time-
limited problems and usually improve and subside 
between the 14th and 16th weeks of pregnancy. In addition 
to altered physiological changes of pregnancy, causal 
factors could be attributed to some medical, surgical, and 
/or gynecological complications occurring at any time 
during the course of pregnancy.  Out of all of these, 
nausea and vomiting are the commonest and clinically 
important ones. The severity of nausea and vomiting may 
affect the physical and psychological/emotional health of 
the pregnant women, as well as family, social and 
occupational functioning and the states of maternal role. 
Some women also considered termination of otherwise 
wanted pregnancies because of severe and prolonged 
nausea and vomiting (1, 2). 
 
Many women lose time to both paid employment and 
housework with significant economic burden. 
Approximately 8.6 million hours per year of paid 
employment and 5.8 million hours per year of housework 
were lost through pregnancy sickness symptoms in 
England and Wales (2).  In the United States, severe 
nausea and vomiting accounts for over 285,000 hospital 
discharges annually (3). In 2002, in USA, the financial 
burden of severe nausea and vomiting was estimated to 
be about $130 million. This figure was based on costs 
associated with an estimated annual average of 39,000 
hospital admissions. It did not include physicians’ fees or 
the loss of productivity at home or on the job or the cost 
of other patient treatment (4).  In Germany, in 2005, the 
yearly cost of hospital admittances alone for hyperemesis 
gravidarum was about 28 million Euros, and the cost of 
lost working hours and outpatient treatment is not even 
included in this amount (5). 
 
The organic, biochemical, metabolic and psychic changes 
and their subsequent complications can be immense 
thereby threatening the basic survival of women. 
Basically, all the body systems can be affected and 
multiple organ failures can be entered as complications in 
the extreme cases. Women with hyperemesis gravidarum 
can lose over 5% of their body weight; suffer fluid and 
electrolyte and acid base imbalances; and moreover risk 
nutritional deficiencies. In some instances long-lasting, 
very intensive vomiting, might in rare cases lead to 
esophageal mucosal injury/tear (a Mallory-Weiss 
syndrome), rupture of esophagus or spleen, choroid 
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bleedings, transient hyperthyroxinemia, pneumothorax as 
well as neurological complications such as myelinolysis 
of the cerebellum or Wernicke encephalopathy caused by 
lack of vitamin B1 (6). 
 
The exact etiologic factor for nausea and vomiting is 
unknown, but it is widely agreed that it is a multifactorial 
condition with genetic, physiological, behavioral, dietary, 
social, and psychological contributing determinants. The 
overall clinical symptoms are believed to be highly 
variable and tend to be affected by the age, marital status, 
place of residence, race/ethnicity, cultural, social, and 
educational status of the individual (7). 
 
The full extent and implications of nausea and vomiting 
in pregnancy warrant early intervention, which is thought 
to decrease the severity and duration of the condition as 
well as prevent complications. However, because of to 
commonality of the condition and rarity in fatality, 
caused by it both care providers and pregnant women 
often tend to minimize the impact of NVP, thus the 
condition is often inadequately treated (7,8). 
 
It is anticipated that this research will add to the growing 
body of knowledge about nausea and vomiting in 
pregnancy and contribute to bridging the information gap 
about this problem in our country as there have not been 
studies done addressing this particular important issue. 
 
Materials 
This study was done at three hospitals; Tikur Anbassa 
Specialized Hospital (SPRH), Ghandi Memorial Hospital 
(GMH) and St Paul’s Hospital (SPH), all of them located 
in Addis Ababa. These particular facilities were chosen 
because they were technically and logistically accessible 
for this study.  The descriptive facility-based cross-
sectional study was conducted from June 1 to August 31, 
2012 in order to assess nausea and vomiting of pregnancy 
on pregnant women attending antenatal care at the 
mentioned hospitals. 
 
The participants were from Addis Ababa and its 
surrounding vicinities and consisted of all pregnant 
women who received antenatal care at those selected 
hospitals during that time. The sample size was 
calculated using the single population proportion formula 
and amounted to 384, where, the P was considered to be 
0.5, the margin of error of 0.5 and 95% confidence level. 
Using a simple random sampling technique, every second 
woman was selected from those coming for ANC from 
Monday through Friday till the desired sample size was 
achieved. 
 
The participants were recruited upon their appearance for 
their routine ANC follow up. All, except four study 
subjects, were of singleton intrauterine gestation. The 
four subjects with twin gestation were not significant to 
be considered separately. Subjects with severe nausea 
and vomiting but diagnosed to have concurrent medical 
or surgical illness were excluded during the recruitment 
period. Each of the subjects was approached by an intern 
or a resident to explain the purpose of the study and to 
determine interest to participate in the study. The survey 
lasted for about 10 minutes and was completed by the 
client herself and/or by a trained data collector and 
returned while the subject was at the clinic for her 
scheduled prenatal visit. The completeness was checked 
by the respective interviewer immediately upon receiving 
the questionnaire. No pregnant woman refused to 
complete the questionnaire. 
 
The semi-structured questionnaire contained both closed 
and open-ended questions which were adopted from 
similar researches done on the outcome of interest. It was 
pretested, refined and then translated into Amharic from 
the English. In addition to the questions used to assess 
NVP, the questionnaire also contained socio-
demographic, obstetric and behavioral determinants. 
 
No gestational age distinction was made as the intention 
was to assess NVP across the three trimesters. This 
survey was targeted only to the time of pregnancy based 
on the assumption that most women would remember 
their particular event of nausea and/or vomiting more 
clearly if surveyed during their pregnancies than after 
delivery. 
 
Ethical approval was obtained from the Department of 
Research and Publication Committee, University of 
Addis Ababa, and permission to conduct the study in the 
chosen hospitals was secured from the responsible 
administrative body in each hospital. 
 
Variables of interest were transferred to Statistical 
Package for Social Sciences (SPSS ver. 20) system file. 
Data were cleaned and edited using frequency runs to 
check for errant and unusual values as well as logical 
inconsistencies. Data were summarized using appropriate 
descriptive statistics. P-value < 0.05 and χ² test were used 
to measure the strength of associations between the 
selected variables with the dependent variable (NVP). 
 
Results 
The age distribution of the study subjects ranged between 
16 – 38 years, 164/384(68.8%) fell between the ages of 
25 – 34 years with a mean age of 27.7 ± 4.37 years. Most 
were Amhara 165/384(43%) in ethnicity, partnered: 
366/384(95.3%), completed elementary education: 
265/384(69%); employed: 181/384(47.1%) and most 
317/384(82.6%) intended to become pregnant (Table1). 
 
The mean and median gestational age at the time of 
interview was 7.5 months (± 1.9 months) and 8 months 
respectively, (range 1.5-9 months), most, 290/384 
(75.5%) were above 7 months and only17/384 (4.4%) 
were in the first trimester. Premigravidity and GII-IV 
account for 111/384 (28.9%) and 247/384 (64.3%), 
respectively. One hundred six (27.6%) of the women had 
one or more history of abortion and 138/384 (35.9%) of 
them had at least one alive child (Table2). 
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Table 1: The socio-demographic and behavioral 








Age (year) = mean age 
27.7±4.37 
  
   <24  82 21.3 
   25-34 264 68.8 
   >35  38 9.9 
Marital status   
   Partnered 366 95.3 
   Non Partnered 18  4.7 
Religion   
   Christian 298 77.6 
   Muslim  86 22.4 
Ethnicity   
   Amhara 165 43.0 
   Oromo  90 23.4 
   Tigre  24  6.3 
   Gurage  80 20.8 
   Others  25  6.5 
Living address   
   Urban 365 94.3 
   Rural 22 5.7 
Occupation   
   Working 181 47.1 
   Not=working 204 52.9 
Educational level   
   ≤ 8th grade 119 31 
   9-12th grade 162 42.2 
   College/University 103 26.8 
Plan of pregnancy   
   Planned 317 82.6 
   Not Planned 67 17.4 
Living arrangement   
   With husband or 





   Alone 12 3.1 
 
 
Table 2: The obstetrical determinants 




Gestational age  
(months = mean 7.5 
months ± 1.9 months, 
median 2 
  
Total Numbers of 
Pregnancies 
  
   1 111 28.9 
   2-4 247 64.3 
   +5  26  6.8 
Parity   
   Nulliparous 154 40.1 
   Primiparous 139 36.2 
   Multiparous  91 23.7 
No of alive children   
   None 164 42.7 
   One 138 35.9 
   2+  82 21.4 
Abortion history   
   No 278 72.4 
   Yes 106 27.6 
 
 
Two hundred eighty six (74.5%) the women experienced 
nausea and/or vomiting during their index pregnancy and 
of these women, 64/384 (16.7%) had nausea only and 
190/384 (49.5%) had both nausea and vomiting occurring 
together, and only 17/384 (4.4%) had severe NVP that 
required admission to a hospital. Excessive salivation and 
food aversion were reported in 159/384 (41.4%) and 
216/384 (56.3%) respectively (Table 3). 
 
Table 3: Prevalence of NVP and associated symptoms 
Characteristics Frequency(n) Percent 
(%) 
NVP symptoms   
  Vomiting only  35    9.1 
   Nausea only  61  15.9 
   Nausea and Vomiting 190  49.5 
   No NVP symptoms  98  25.5 
   Total 384 100.0 
Admitted for sever 
NVP (N=384) 
  
   Yes 17   4.4 




















As shown in Table 4, 262/384 (91.6 %) of women had 
onset of NVP before the third month of pregnancy, and 
the mean gestational age for onset of NVP symptoms was 
2.15 months ± 1.16. Of the women with NVP, 147/286 
(51.4%) had an early pattern of symptoms, 168/286 
(58.7%) had one to two episodes of vomiting per day and 
243/286 (85%) were triggered by tasting and/or smelling. 
About 74 (25.9%) experienced loss work time (either 
paid job or housework) and 95 (33.2%) had affected 
marital relationships because of NVP. 
 
Regarding relieving factors, 54/286 (18.9%) reported 
having used pharmacological methods of whom 50 
(92.3%) used antiemetic medications. Among the 
traditional remedies used, lemon was the most 
frequented. Ninety seven (33.9%) of the women went to 
health institution for their symptoms with a Mean OPD 
visit of 1.82 ± 1.04 (range 1-4 days) and 55.7% of them 
were given medication to relieve symptoms. Among 
women having an OPD visits 17 (17.5%) were admitted 
for severe NVP and half of them were hospitalized for 
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Table 4:  Symptom characteristics and some impacts 





GA at onset of 
symptoms (months) = 
Mean 2.15 months ± 
1.16 
  
   Onset up to 2 months 196  68.5 
   > 2 up to 3 months  66  23.1 
   < 3 up to 5 months  18   6.3 
   > 5 months   6   2.1 
   Total 286 100.0 
Pattern of symptoms   
   Early 147  51.4 
   Late  66  23.1 
   Irregular  73  25.5 
   Total 286 100.0 
No of vomiting per day   
   1-2 132 58.7 
   3-4  72 32.0 
   5+  21 9.3 
   Total 225 100.0 
Triggers of symptoms 
of NVP 
  
   Smell only  90  31.5 
   Taste only  63  22.0 
   Both Taste & Smell  90  31.5 
   No Trigger  43  15.0 
   Total 286 100.0 
Effect of NVP   
   Loss to work  





   Total 286 100.0 
Marital relationship   
   Yes  95  33.2 
   Total 286 100.0 
Table 5:  Measures taken to alleviate symptoms of 
NVP 
What is used to 
ease NVP 
Frequency (n) Percentage 
% 
   None 220  76.9 
   Medication  54  18.9 
   Traditional 
remedies 
 12   4.2 
   Total 286 100.0 
Mgt at outpatient   
   Medication used  54  55.7 
   Non medication 





   Total  97 100.0 
Number of OPD 
visit = mean 1.82 ± 






   (yes)  17   5.9 
   Total 286 100.0 
 
No significant association was observed with the socio- 
demographic variables like age, ethnicity, place of 
residence, occupation, and educational level except 
marital status with NVP and severe NVP. Pregnant 
women, who were not partnered were significantly 
associated with NVP and severe NVP (p=<0.05). Some 
GI symptoms such as excessive salivation, pica and food 
aversion were also significantly associated with 
symptoms of NVP. Behavioral determinants such as 
living arrangement and plans of pregnancy were not 
significantly associated either with NVP or severe NVP 
(Table 6). 
 
Table 6:  Comparison of women with NVP and determinants of NVP 
NVP N % χ²  df p-value 
GI symptoms      
   Excessive salivation   (Yes) 159 41.4  49.4 1 <0.0001 
   Pica                            (Yes)  78 20.3   8.31 1   0.004 
   Food aversion            (Yes) 216 56.2  76.73 1 <0.0001 
Marital status      
   No partner  18 6.3   6.687 1   0.010 
   Partner 268 93.7    
Gravidity      
   1  97 33.9  13.7 1 <0.0001 
   2+ 189 66.1    
Parity      
   0 132 46.2  17.1 1 <0.0001 
   1+  154 53.8    
Number of Children      
   0  139 48.6  15.91 1 < 00001 
   1+  147 51.4    
 
 
Obstetrical variables such as primgravidity, nulliparity 
and having no live children were significantly associated 
with the outcome variable (NVP) (p < 0.05). However, 
gestational age at interview had no association with NVP. 
 
Severe NVP was found to be significantly associated 
with loss of work, marital relationships, antiemetic use 
and also with more frequent episodes of vomiting with p 
value <0.05 (Table 7). 
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Table 7: Comparison of severe NVP and determinants of nausea and vomiting 
Severe NVP n  % χ²  df p-value , Fisher’s  
Marital status      
   Partnered 14 82.4    
   Non Partnered 3  17.6 6.471  1 0.039 
Frequency of vomiting      
   <5 12 70.6    
   5+ 5 29.4 8.76 1 0.013 
Affected relationship      
   No 6 35.3    
   Yes  11 64.7 8.08 1 0.007 
Loss of work       Yes   17 100 51.8 1 <0.0001 
Antiemetic use   Yes 17 100 19.38 1 <0.0001 
 
 
No significant difference for early severity and frequency 
of symptoms was observed when comparing those 
women who had less than 5 episodes of symptoms in up 
to 2 months from their LMP with those who had 
experienced more than 5 episodes of symptoms in up to 3 
months from LMP. GA at onset of symptom showed no 
association with pattern of symptom, admission for 
severity, medication or marital relationship. 
 
A significant association was observed with early onset 
of symptoms and more frequent episodes of vomiting for 
those who lost time to work compared to those who lost 
no time from work with the p  value <0.05 (Table 8). 
 
Table 8: Comparison of loss of work and symptom characteristics of NVP 
Variables n  % χ²  df p-value   
Onset of symptom      
   Early onset(<2mo)  196 68.5    
   Late onset(>2mo) 90 31.5 4.49 1 0.003 
Frequency of vomiting      
   <5 58 84.1    
   5+ 11 15.9 5.14 1 (Fisher’s =0.044) 
 
Discussion 
The high prevalence of NVP in our study (74.5%), is 
similar to the rates (50%-90%) found in other studies (1, 
2). The high prevalence supports that this is a normal 
physiologic occurrence in early pregnancy. The finding 
in our study that 9.8% of pregnant women experienced 
late NVP symptoms is in agreement with previous 
studies that showed approximately 10-32% of women 
experiencing late NVP symptoms (4, 6-8, 10). 
 
The onset of symptoms in the 1st trimester (91.6%) and 
only 2.1% after 5 months of pregnancy observed in our 
study is in conformity with different studies reported , 90 
% onset of symptoms in first trimester and only 5% after 
22 weeks of pregnancy (11, 12). 
 
Similarly, the finding in our study that 16.9 % had nausea 
only and 49.6% had both nausea and vomiting occurring 
together is comparable to the Gads by et al study which 
demonstrated that 25% had nausea only and 52% 
reported both nausea and vomiting (13). 
 
The finding in our study of severe NVP, 6.1%, is lower 
than the Canadian and the Swedish reports of 19% and 
17% respectively, (9, 14). This difference in the degree 
of severity is apparent because of the difference in 
methodology and definition of severity used, in our 
study, severe NVP was defined as a symptom that 
required hospital admission while in other studies a NVP 
index scale measure was used for grading severity of 
nausea and vomiting. 
 
NVP onset and severity decreased significantly with 
gestational age among women in the first and second 
trimesters of pregnancy. This is reasonable since the 
natural history of NVP is gradual improvement of 
symptoms as pregnancy progresses corresponding with 
the onset, peak and decline of maternal HCG levels. This 
association is well demonstrated in the present study as 
well. 
 
It has been thought that symptoms of NVP occur mostly 
in the morning hours, which was indeed the most 
common period observed in our study subjects, where 
147/286 (51.4%) of women experienced only morning 
symptom while 73 (25.5%) had symptoms at various 
times throughout the day (13, 14). A comparative 
analysis, however, is obviously difficult as daily diary 
registration of symptoms than self report as in our study 
was applied by others. 
 
The study subjects of patients who had at least one 
episode of vomiting 167/286 (58.4%) in our subjects 
corresponds well with the previous findings of by Gads et 
al and the Tierson et al study. Associated gastrointestinal 
symptoms, including excessive salivation, food aversion 
and food cravings were found to be significantly related 
to reports of nausea and/or vomiting. The subjects, who 
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did not experience nausea and vomiting, reported the 
least number of gastrointestinal symptoms (16, 17).  
 
The way in which a pregnant woman responded to the 
primary stimulus to nausea and vomiting of pregnancy 
depended on her susceptibility mediated by vestibular, 
gastrointestinal, olfactory, and behavioral pathways. 
Smell appeared to be a major trigger of symptom in our 
study (63%); this is comparable to Lacroix R et al, 
wherein 50% of women, olfaction appeared to be the 
primary mechanism involved that made nausea worse  
(18, 20).   
 
Contrary to most reports, of the socio-demographic 
variables studied, only not being partnered showed 
significant association with NVP/severe NVP. Similarly, 
contrasting results were obtained compared to other 
reports with regards to the association between NVP and 
race/ethnicity, unintended pregnancy, and place of 
residence. These differences may have resulted from the 
difference in methodology, that is, some of these studies 
that found such associations were focused on severe NVP 
(hyperemesis gravidarum) or vomiting alone (16, 19, 21- 
24),  
 
In conformity with other studies, nullipara women, 
primigravida women, or those with no child were found 
to be significantly associated with NVP. This may be due 
to stress and exposure to high levels of HCG for the first 
time (25, 26, 28).  
 
NVP can have a significant impact on family life, on the 
ability to perform usual daily activities and on social 
functioning. In addition, the presence and severity of 
NVP have been shown to have an impact on the quality 
of life of pregnant women. We found significant 
association between severe NVP and negatively affected 
marital relationships. We observed a strong association 
between loss of work time and the severity in frequency 
of pregnancy symptoms and severe NVP. In one study it 
was calculated that 12% of patients found ordinary work 
during pregnancy impossible. In another study, 57% of 
women were working during pregnancy and about 35% 
needed time off from their paid employment and 25% 
needed time away from their house work (13, 14, 30, 34). 
 
Regarding what women used to ease nausea and 
vomiting, most (76.9%), in our subjects did not take anti-
emetics or alternative medications or non-drug 
alternatives or traditional remedies to alleviate their 
symptoms. This is may be from the fact that most women 
may feel NVP as a sign of early pregnancy and is 
temporary requiring no treatment as such. In our study 
medication was used in about 18.9%, of whom 91.6% 
used anti-emetics. This is similar to Lacasse et al report, 
where, 20.4% reported that they used anti-emetic 
medications. It is shown that the severity of NVP was the 
factor most closely related to women’s decisions to take 
antiemetic medication. The same studies affirmed 
significant association between the use of antiemetic 
medications to ease NVP and hospital admission for 
severe nausea and vomiting connected with compared to 
women who did not use antiemetic medications. This 
may be due to physicians’ decision to use antiemetic 
medications which may be as consequence of severe 
nausea and vomiting symptoms at their presentation to 
clinic (31, 40).  
 
In our study, 14 (82.4%) out of 17 women with severe 
NVP were admitted at or before 2 months of gestation 
and 8 (47.1%) of them had readmission for recurrence of 
severe symptoms. It was observed that the peak incidence 
of admission for hyperemesis gravidarum was reported to 
be between 8-12 weeks (57%), while only 5% were 
admitted before eight weeks of gestation and 25% of the 
patients required re-admission to hospital because of the 
recurrence of symptoms for the mere reason that some of 
the patients may have been discharged too soon (41). 
This disparity could be explained by the difference in 
methodology and the characteristics of the population.       
 
In conclusion, three fourth of women had symptoms of 
nausea and/or pregnancy and severe symptoms were 
reported in 4.4% only, which is comparable to the 
currently available body of literature. The strong 
associations observed between severe NVP and marital 
status, frequency of vomiting, early onset of symptom, 
loss of work time, and marital relationship. Gestational 
age was described in months, because of the design of the 
study (retrospective) and none of the subjects could 
preferentially describe the GA in weeks as observed in 
the preparatory phase.  As most of the respondents were 
in advanced gestation during the interview, with no 
custom of keeping health diary or menstrual calendar, the 
possibility of information (recall) bias cannot be 
excluded. Severity measured on admission criteria could 
miss those without admission but yet could have had 
significant perceived morbidity. From this cross-sectional 
study, it is impossible to determine causal relationships. 
Hence, whether these are methodological artifacts or are 
etiologically significant findings requires further 
investigation and a large-scale prospective national study. 
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